SRPT Sarepta Therapeutics PE ratio, current and historical analysis

As of Apr 25, 2025, the Sarepta Therapeutics stock's PE ratio is 24.47. This results from the current EPS of $2.47 and stock price of $60.44. The P/E ratio has a decrease of 85% from the past four quarters average of 163.9.

SRPT PE ratio history

How has SRPT's PE ratio performed in the past
Today
24.47
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Sarepta Therapeutics PE ratio by year

Year PE ratio PE change Price EPS
2024 49.23 N/A $121.59 $2.47
2023 N/A N/A $96.43 -$5.8
2022 N/A N/A $129.58 -$8.03
2021 N/A N/A $90.05 -$5.15
2020 N/A N/A $170.49 -$7.11
2019 N/A N/A $129.04 -$9.71
2018 N/A N/A $109.13 -$5.46
2017 N/A N/A $55.64 -$0.86
2016 N/A N/A $27.43 -$5.49
2015 N/A N/A $38.58 -$5.2
2014 N/A N/A $14.47 -$3.39
2013 N/A N/A $20.37 -$3.31
2012 N/A N/A $25.8 -$5.14
2011 N/A N/A $4.47 -$0.11
2010 N/A N/A $12.72 -$1.74

Sarepta Therapeutics PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 49.23 -38.51% $121.59 $2.47
Sep 2024 80.06 -62% $124.89 $1.56
Jun 2024 210.67 -33.28% $158 $0.75
Mar 2024 315.76 N/A $129.46 $0.41
Dec 2023 N/A N/A $96.43 -$5.8
Sep 2023 N/A N/A $121.22 -$7.83
Jun 2023 N/A N/A $114.52 -$10.31
Mar 2023 N/A N/A $137.83 -$12.69
Dec 2022 N/A N/A $129.58 -$8.03
Sep 2022 N/A N/A $110.54 -$8.22
Jun 2022 N/A N/A $74.96 -$5.88
Mar 2022 N/A N/A $78.12 -$4.25
Dec 2021 N/A N/A $90.05 -$5.15
Sep 2021 N/A N/A $92.48 -$6.13
Jun 2021 N/A N/A $77.74 -$8.03

SRPT average PE ratio chart

What is the average PE ratio of SRPT for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

SRPT PE vs peers

What is SRPT's PE ratio compared to its peers

Compared to its peer stock GILD, SRPT's PE ratio stands lower.

Stock name PE ratio Market cap
SRPT Sarepta Therapeutics Inc 24.47 $5.86B
GILD Gilead Sciences Inc 271.5 $128.48B
NVAX Novavax Inc N/A $1.07B
PTCT Ptc Therapeutics Inc N/A $3.91B
BCRX Biocryst Pharmaceuticals Inc N/A $1.75B
ALNY Alnylam Pharmaceuticals Inc N/A $32.57B
RNA Avidity Biosciences Inc N/A $3.71B
INSM INSMED Inc N/A $12.61B

Frequently asked questions

What is Sarepta Therapeutics's PE ratio?

The price to earnings ratio for SRPT stock is 24.47 as of Apr 25, 2025.

How is SRPT's PE ratio calculated (Sarepta Therapeutics PE ratio formula)?

You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Apr 25, 2025), Sarepta Therapeutics's stock price is $60.44. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $2.47. Therefore, Sarepta Therapeutics's P/E ratio for today is 24.47. PE RATIO(24.47) = STOCK PRICE($60.44) / TTM EPS($2.47)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.